Problematic “add-ons” to IVF, first birth after spindle transfer, and more – May 2017 CHR VOICE Digest

As CHR’s years-long construction finally nears completion, we address a number of concerns in the IVF field in this month’s VOICE, including the dubious commercial push for various “add-on” tests and treatments to IVF, an increasingly obvious conflict of interest playing out in the editorial direction of the main industry journal Fertility & Sterility, and some troubling revelations about the first IVF baby born after a spindle cell transfer to prevent transmission of a mitochondrial disease. On a brighter note, CHR and collaborators won the Presidential Poster Competition in the 2017 Endocrine Society meeting, and a new CHR baby wears an awesome onesie. Read this issue in PDF.

In this issue, we cover:


Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.